A review of new science, in plain language

Proceedings of the National Academy of Sciences  ·  31 July 2026  ·  From issue 15

Blocking antibodies in myasthenia gravis patients raised the risk of severe COVID pneumonia up to 12 times.

Adrian Gervais, Astrid Marchal et al., High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies, Proceedings of the National Academy of Sciences.

Integrity screen: passed (3 checks) Checked 3 August 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 15 15 papers
More from Proceedings of the National Academy of Sciences